Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is proud to announce the launch of its D
The Nobel Prize in Physiology or Medicine awarded
This year, the Hamburg based life sciences company
Alembic Pharmaceuticals Ltd., t
Since it’s an ingredient in so many foods, you h
Dear Readers, Welcome to the latest issue of Micr
Roche drug Hemlibra has a good chance to become the first choice of treatment for the patients who are suffering from Hemopilia.Basically, Hemlibra is a humanized monoclonal antibody drug for the treatment of haemophilia which is given through an injection, it was observed that it reduces the bleed dramatically in hemphilia tests.
At the world Federation of Hemophilia’s world congress in Scotland,Roche’s-Genentech unit disclosed the details from the twophases 3 studies on emicizumab. The trails were termed as HEAVEN-3 & HEAVEN-4.
At the world Federation of Hemophilia’s world congress in Scotland,Roche’s-Genentech unit disclosed the details from the twophases 3 studies on emicizumab. The trails were termed as HEAVEN-3 & HEAVEN-4..
It was reported that Hemlibra was able to cut down 96% of the bleeds in Hemophilia. Some comparisons were observed between a patient who didn’t received preventive treatment whereas a patient who received the preventive treatment in the form of clotting factors it reduces them by 68%.
The firm will submit the new data to regulators in the U.S. and Europe for approval.
